Medtronic (NYSE:MDT) and Boston Scientific (NYSE:BSX) both face patient lawsuits related to spinal cord stimulation (SCS) ...

GE HealthCare (Nasdaq: GEHC) today unveiled Signa Sprint, an ultra-premium wide-bore 1.5% high-performance gradient MRI ...

Blue Cross Blue Shield of Michigan (BCBSM) and Blue Care Network created a new medical policy for histotripsy.

Globus Medical stock is down today on an unexpectedly soft Q1 amid an earlier-than-planned integration with recently acquired ...

Solventum, spun off from 3M in April 2024, reported $2.1 billion in sales for the first quarter of 2025, an increase of 2.6%.

The Andover, Massachusetts–based medtech company, which offers an organ care system (OCS) for transplant therapy, hit $143.5 ...

Bausch + Lomb announced today that it received CE mark approval for its LuxLife full range of vision intraocular lens (IOL).

SS Innovations plans to submit a de novo classification request to the U.S. FDA for its SSi Mantra 3 surgical robotic system.

GE HealthCare (Nasdaq: GEHC) announced today that it received FDA 510(k) clearance for its Aurora nuclear medicine system and ...

Enovis beat earnings expectations in its first quarter 2025 results out today, but the market reaction was tempered.

Endospan today announced the presentation of 30-day results from a study evaluating its Nexus aortic arch stent graft system.

Boston Scientific (NYSE: BSX) + Boston Scientific Corp. $104.068 0.15% Open 104.222 Day High 104.79 52 Week High 79.43 52 ...